Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city
Beatrice Setnik, Lynn R. Webster(Adherent Technologies (United States)), Glenn C. Pixton(Pfizer (United States)), Naama Levy‐Cooperman(Vale (Canada)), Ira Smith(Vale (Canada)), Carl L. Roland(Pfizer (United States)), Veeraindar Goli(Duke University)
Cited by 14
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309
A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain
|Journal of Pain and Symptom Management|2006|304